Excelsior Correspondent
JAMMU, Aug 30: The American Oncology Institute (AOI) at ASCOMS Jammu has marked a significant milestone in cancer care with the successful completion of a complex liver surgery, known as a bi-segmentectomy, on a 56-year-old patient diagnosed with liver cancer. This advanced surgical procedure, which requires a high level of expertise and state-of-the-art equipment, represents a major advancement in cancer treatment in the region.
The surgery was conducted by AOI Jammu’s distinguished surgical oncology team, led by Dr Avinash Rajra and Dr Sujeet Bhat, with crucial support from the anesthesia team, including Dr Atul Sharma and Dr Khuram Malik. The bi-segmentectomy involved the meticulous removal of the tumor along with a margin of healthy liver tissue, ensuring a thorough and effective surgical intervention.
Harish Trivedi, CEO of the American Oncology Institute, emphasized the importance of this achievement, stating, “This milestone underscores our commitment to providing world-class cancer care in every region we serve. The successful execution of this complex surgery demonstrates the exceptional coordination and expertise of our multidisciplinary team at the Jammu facility.”
Dr Avinash Rajra, Surgical Oncologist at AOI ASCOMS Jammu, expressed satisfaction with the successful outcome, noting, “This successful bi-segmentectomy highlights the capabilities of our team and signifies a new chapter in the treatment options available to our patients. Our commitment to delivering top-tier cancer care is evident in the smooth recovery and positive outcome for our patient.”
The patient’s post-operative recovery was smooth, with no complications reported. He was discharged on the fifth day following the surgery and is currently recovering well at home.
Dr Neeraj Bishnoi, RCOO, AOI North Region, added, “This achievement is a testament to AOI’s dedication to offering cutting-edge medical interventions that make a real difference in our patients’ lives. We are committed to advancing our medical offerings to meet the needs of our community, ensuring that advanced cancer treatments are both accessible and effective.”